{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:37:02Z","timestamp":1789043822900,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP15K15419"],"award-info":[{"award-number":["JP15K15419"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18H02829"],"award-info":[{"award-number":["JP18H02829"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K08296"],"award-info":[{"award-number":["JP18K08296"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["J20ek0410053h0003"],"award-info":[{"award-number":["J20ek0410053h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jaut.2021.102774","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T13:56:45Z","timestamp":1639058205000},"page":"102774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Cell surface-expressed Ro52\/IgG\/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3966-3437","authenticated-orcid":false,"given":"Noriko","family":"Arase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0382-5142","authenticated-orcid":false,"given":"Hyota","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hachiro","family":"Konaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Tonomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorihisa","family":"Kotobuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-5691","authenticated-orcid":false,"given":"Ikuko","family":"Ueda-Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiko","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yorifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Murota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Ohmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4749-7117","authenticated-orcid":false,"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Arase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3062-4872","authenticated-orcid":false,"given":"Manabu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2021.102774_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102774_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","article-title":"Classification of myositis","volume":"14","author":"Lundberg","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102774_bib3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/BOR.0000000000000329","article-title":"Recent advances in dermatomyositis-specific autoantibodies","volume":"28","author":"Fujimoto","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102774_bib4","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1084\/jem.167.5.1560","article-title":"A 52-kD protein is a novel component of the SS-A\/Ro antigenic particle","volume":"167","author":"Ben-Chetrit","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102774_bib5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102774_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/08916934.2012.732131","article-title":"Clinical associations of anti-SSA\/Ro60 and anti-Ro52\/TRIM21 antibodies: diagnostic utility of their separate detection","volume":"46","author":"Menendez","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2021.102774_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12948-018-0084-9","article-title":"Bench to bedside review of myositis autoantibodies","volume":"16","author":"Palterer","year":"2018","journal-title":"Clin. Mol. Allergy"},{"key":"10.1016\/j.jaut.2021.102774_bib8","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102774_bib9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2021.102774_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08916930600623791","article-title":"In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease","volume":"39","author":"La Corte","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2021.102774_bib11","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3899\/jrheum.150844","article-title":"Rituximab in the treatment of Jo1 antibody-associated antisynthetase syndrome: anti-ro52 positivity as a marker for severity and treatment response","volume":"43","author":"Bauhammer","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102774_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00296-009-0884-9","article-title":"Characteristics of interstitial lung disease in SS-A positive\/Jo-1 positive inflammatory myopathy patients","volume":"29","author":"Vancsa","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"9","key":"10.1016\/j.jaut.2021.102774_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-216372","article-title":"Association of anti-Ro52 autoantibodies with interstitial lung disease in connective tissue diseases","volume":"80","author":"Wu","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102774_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102774_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","article-title":"Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy","volume":"109","author":"Rutjes","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102774_bib16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102774_bib17","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/annrheumdis-2018-215004","article-title":"Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis","volume":"78","author":"Sabbagh","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102774_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.rmed.2019.07.020","article-title":"Clinical characteristics of dermatomyositis patients with isolated anti-Ro-52 antibody associated rapid progressive interstitial lung disease: data from the largest single Chinese center","volume":"155","author":"Chen","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2021.102774_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102774_bib20","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1002\/art.22856","article-title":"Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients","volume":"56","author":"Cooper","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102774_bib21","first-page":"1009","article-title":"Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature","volume":"27","author":"Rios Fern\u00e1ndez","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102774_bib22","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/rheumatology\/ker088","article-title":"Rituximab treatment in patients with refractory inflammatory myopathies","volume":"50","author":"Mahler","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2021.102774_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2012.01.014","article-title":"The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review","volume":"39","author":"Oke","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102774_bib24","volume":"vol. 7","author":"Dickson","year":"2018"},{"key":"10.1016\/j.jaut.2021.102774_bib25","doi-asserted-by":"crossref","first-page":"10440","DOI":"10.1073\/pnas.1806314115","article-title":"TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination","volume":"115","author":"Bottermann","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2021.102774_bib26","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.it.2017.07.005","article-title":"TRIM21 and the function of antibodies inside cells","volume":"38","author":"Rhodes","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2021.102774_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/intimm\/dxs155","article-title":"Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules","volume":"25","author":"Jiang","year":"2013","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2021.102774_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ai.2015.09.005","article-title":"Rheumatoid rescue of misfolded cellular proteins by mhc class II molecules: a new hypothesis for autoimmune diseases","volume":"129","author":"Arase","year":"2016","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jaut.2021.102774_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jb\/mvv093","article-title":"Cellular misfolded proteins rescued from degradation by MHC class II molecules are possible targets for autoimmune diseases","volume":"158","author":"Arase","year":"2015","journal-title":"J. Biochem."},{"key":"10.1016\/j.jaut.2021.102774_bib30","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood-2014-08-593624","article-title":"beta2-Glycoprotein I\/HLA class II complexes are novel autoantigens in antiphospholipid syndrome","volume":"125","author":"Tanimura","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102774_bib31","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/art.40170","article-title":"Myeloperoxidase\/HLA class II complexes recognized by autoantibodies in microscopic polyangiitis","volume":"69","author":"Hiwa","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102774_bib32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bjd.15571","article-title":"Novel autoantibody against the beta2-glycoprotein I\/human leucocyte antigen-DR complex in patients with refractory cutaneous ulcers","volume":"178","author":"Arase","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102774_bib33","series-title":"The Beta2-Glycoprotein I\/HLA-DR Complex Is the Major Autoantibody Target in Obstetric Antiphospholipid Syndrome","author":"Tanimura","year":"2020"},{"key":"10.1016\/j.jaut.2021.102774_bib34","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1073\/pnas.1401105111","article-title":"Autoantibodies to IgG\/HLA class II complexes are associated with rheumatoid arthritis susceptibility","volume":"111","author":"Jin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2021.102774_bib35","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"European league against rheumatism\/American college of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102774_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000507","article-title":"EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report","volume":"3","author":"Bottai","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2021.102774_bib37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102774_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/s10165-004-0338-x","article-title":"Revised Japanese criteria for Sj\u00f6gren\u2019s syndrome (1999): availability and validity","volume":"14","author":"Fujibayashi","year":"2004","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102774_bib39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2021.102774_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2021.102774_bib41","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1073\/pnas.0609174104","article-title":"Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function","volume":"104","author":"James","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2021.102774_bib42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/imr.12363","article-title":"TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity","volume":"268","author":"Foss","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2021.102774_bib43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbrc.2018.12.106","article-title":"Invariant chain p41 mediates production of soluble MHC class II molecules","volume":"509","author":"Shishido","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jaut.2021.102774_bib44","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(83)90629-3","article-title":"Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity","volume":"2","author":"Bottazzo","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2021.102774_bib45","doi-asserted-by":"crossref","first-page":"106134","DOI":"10.1016\/j.rmed.2020.106134","article-title":"Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis","volume":"172","author":"Xing","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2021.102774_bib46","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00296-019-04398-2","article-title":"Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review","volume":"39","author":"Huang","year":"2019","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2021.102774_bib47","article-title":"Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis\/dermatomyositis","volume":"98","author":"Temmoku","year":"2019","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2021.102774_bib48","series-title":"Risk Prediction Modeling Based on a Combination of Initial Serum Biomarkers in Myositis-Associated Interstitial Lung Disease","author":"Gono","year":"2020"},{"key":"10.1016\/j.jaut.2021.102774_bib49","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1080\/14397595.2018.1548918","article-title":"Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis","volume":"29","author":"Nishioka","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102774_bib50","first-page":"2413","article-title":"Impaired clearance of apoptotic cardiocytes is linked to anti-SSA\/Ro and -SSB\/La antibodies in the pathogenesis of congenital heart block","volume":"116","author":"Clancy","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2021.102774_bib51","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0891-5849(02)00797-9","article-title":"Oxidative stress mediates cell surface expression of SS-A\/Ro antigen on keratinocytes","volume":"32","author":"Saegusa","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jaut.2021.102774_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/1523-1747.ep12873930","article-title":"Binding of antibodies to the extractable nuclear antigens SS-A\/Ro and SS-B\/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus","volume":"94","author":"Furukawa","year":"1990","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2021.102774_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/08916939508995297","article-title":"Stress-induced cell surface expression and antigenic alteration of the Ro\/SSA autoantigen","volume":"22","author":"Igarashi","year":"1995","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2021.102774_bib54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1104904","article-title":"Endogenous MHC class II processing of a viral nuclear antigen after autophagy","volume":"307","author":"Paludan","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jaut.2021.102774_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002455","article-title":"Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2","volume":"7","author":"Zuo","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2021.102774_bib56","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease","volume":"23","author":"Sato","year":"2013","journal-title":"Mod. Rheumatol."}],"updated-by":[{"DOI":"10.1016\/j.jaut.2022.102797","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000}}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121001827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121001827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:29:16Z","timestamp":1760257756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121001827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":56,"alternative-id":["S0896841121001827"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102774","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell surface-expressed Ro52\/IgG\/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102774"}}